Clinical trial
Northern Colorado Coronavirus Biobank: A Biorepository for Acute and Convalescent Patient Samples From Coloradoans Infected With SARS-CoV-2 (Severe Acute Respiratory Syndrome-Coronavirus-2)
NCT04603677 is registered in ClinicalTrials.gov with Colorado State University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Northern Colorado Coronavirus Biobank: A Biorepository for Acute and Convalescent Patient Samples From Coloradoans Infected With SARS-CoV-2 (Severe Acute Respiratory Syndrome-Coronavirus-2)
- Lead sponsor
- Colorado State University
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 8, 2020
- Completion date
- February 28, 2023
- Enrollment
- 148 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
covid19